Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort


Por: Westwood, S, Baird, AL, Anand, SN, Nevado-Holgado, AJ, Kormilitzin, A, Shi, L, Hye, A, Ashton, NJ, Morgan, AR, Bos, I, Vos, SJB, Baker, S, Buckley, NJ, Ten Kate, M, Scheltens, P, Teunissen, CE, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, EE, Sleegers, K, Frisoni, GB, Blin, O, Richardson, JC, Bordet, R, Molinuevo, JL, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleo, A, Sala, I, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Freund-Levi, Y, Frolich, L, Dobricic, V, Legido-Quigley, C, Bertram, L, Barkhof, F, Zetterberg, H, Morgan, BP, Streffer, J, Visser, PJ, Lovestone, S

Publicada: 1 ene 2020
Resumen:
We have previously investigated, discovered, and replicated plasma protein biomarkers for use to triage potential trials participants for PET or cerebrospinal fluid measures of Alzheimer's disease (AD) pathology. This study sought to undertake validation of these candidate plasma biomarkers in a large, multi-center sample collection. Targeted plasma analyses of 34 proteins with prior evidence for prediction of in vivo pathology were conducted in up to 1,000 samples from cognitively healthy elderly individuals, people with mild cognitive impairment, and in patients with AD-type dementia, selected from the EMIF-AD catalogue. Proteins were measured using Luminex xMAP, ELISA, and Meso Scale Discovery assays. Seven proteins replicated in their ability to predict in vivo amyloid pathology. These proteins form a biomarker panel that, along with age, could significantly discriminate between individuals with high and low amyloid pathology with an area under the curve of 0.74. The performance of this biomarker panel remained consistent when tested in apolipoprotein E epsilon 4 non-carrier individuals only. This blood-based panel is biologically relevant, measurable using practical immunocapture arrays, and could significantly reduce the cost incurred to clinical trials through screen failure.

Filiaciones:
Westwood, S:
 Univ Oxford, Dept Psychiat, Oxford, England

Baird, AL:
 Univ Oxford, Dept Psychiat, Oxford, England

Anand, SN:
 Univ Oxford, Dept Psychiat, Oxford, England

Nevado-Holgado, AJ:
 Univ Oxford, Dept Psychiat, Oxford, England

Kormilitzin, A:
 Univ Oxford, Dept Psychiat, Oxford, England

Shi, L:
 Univ Oxford, Dept Psychiat, Oxford, England

Hye, A:
 Kings Coll London, Maurice Wohl Clin Neurosci, Inst Psychiat Psychol & Neurosci, London, England

Ashton, NJ:
 Kings Coll London, Maurice Wohl Clin Neurosci, Inst Psychiat Psychol & Neurosci, London, England

 Univ Gothenburg, Dept Psychiat & Neurochem, Molndal, Sweden

 Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden

Morgan, AR:
 Cardiff Univ, Dementia Res Inst Cardiff, Cardiff, Wales

Bos, I:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiatty & Neuropsychol, Maastricht, Netherlands

Vos, SJB:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiatty & Neuropsychol, Maastricht, Netherlands

Baker, S:
 Janssen R&D, Titusville, NJ USA

Buckley, NJ:
 Univ Oxford, Dept Psychiat, Oxford, England

Ten Kate, M:
 Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands

Scheltens, P:
 Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands

Teunissen, CE:
 Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands

Vandenberghe, R:
 Univ Hosp Leuven, Leuven, Belgium

Gabel, S:
 Univ Hosp Leuven, Leuven, Belgium

 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

Meersmans, K:
 Univ Hosp Leuven, Leuven, Belgium

 Katholieke Univ Leuven, Lab Cognit Neurol, Dept Neurosci, Leuven, Belgium

Engelborghs, S:
 Univ Antwerp, Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol & Memory Clin, Antwerp, Belgium

 Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium

De Roeck, EE:
 Univ Antwerp, Hosp Network Antwerp ZNA Middelheim & Hoge Beuken, Dept Neurol & Memory Clin, Antwerp, Belgium

 Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium

Sleegers, K:
 Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium

 VIB, Ctr Mol Neurol, Neurodegenerat Brain Dis Grp, Brussels, Belgium

Frisoni, GB:
 Univ Geneva, Geneva, Switzerland

 IRCCS Ist Ctr San Giovanni Dio Fatebenefratelli, Brescia, Italy

Blin, O:
 AIX Marseille Univ, AP HM, INS, Marseille, France

Richardson, JC:
 GlaxoSmithKline R&D, Neurosci Therapeut Area, Stevenage, Herts, England

Bordet, R:
 Univ Lille, CHU Lille, INSERM, Lille, France

Molinuevo, JL:
 Hops Clin IDIBAPS, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain

 Unversitat Pompeu Fabra, Barcelona Beta Brain Res Ctr, Barcelona, Spain

Rami, L:
 Unversitat Pompeu Fabra, Barcelona Beta Brain Res Ctr, Barcelona, Spain

Wallin, A:
 Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden

Kettunen, P:
 Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden

Tsolaki, M:
 Ahepa Univ Hosp, Dept Neurol 1, Makedonia, Thessaloniki, Greece

Verhey, F:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiatty & Neuropsychol, Maastricht, Netherlands

Lleo, A:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain

Sala, I:
 Hosp Santa Creu & Sant Pau, Dept Neurol, Barcelona, Spain

Popp, J:
 Univ Hosp Lausanne, Lausanne, Switzerland

 Geneva Univ Hosp, Dept Mental Hlth & Psychiat, Geriatr Psychiat, Geneva, Switzerland

Peyratout, G:
 Univ Hosp Lausanne, Lausanne, Switzerland

Martinez-Lage, P:
 CITA Alzheimer Fdn, San Sebastian, Spain

Tainta, M:
 CITA Alzheimer Fdn, San Sebastian, Spain

Johannsen, P:
 Copenhagen Univ Hosp, Rigshosp, Danish Dementia Res Ctr, Copenhagen, Denmark

Freund-Levi, Y:
 Kings Coll London, Maurice Wohl Clin Neurosci, Inst Psychiat Psychol & Neurosci, London, England

 Karolinska Inst, Dept Neurobiol, Caring Sci & Soc NVS, Div Clin Geriatr, Stockholm, Sweden

 Karolinska Univ Hosp Huddinge, Dept Geriatr Med, Stockholm, Sweden

Frolich, L:
 Heidelberg Univ, Zent Inst Seel Gesundheit, Dept Geriatr Psychiat, Mannheim, Germany

Dobricic, V:
 Univ Lubeck, Inst Neurogenet & Cardiogenet, Lubeck Interdisciplinary Platform Genome Analyt, Liibeck, Germany

Legido-Quigley, C:
 Kings Coll London, London, England

 Steno Diabet Ctr, Syst Med Grp, Gentofte, Denmark

Bertram, L:
 Univ Lubeck, Inst Neurogenet & Cardiogenet, Lubeck Interdisciplinary Platform Genome Analyt, Liibeck, Germany

 Univ Oslo, Dept Psychol, Oslo, Norway

Barkhof, F:
 Vrije Univ Amsterdam, Dept Radiol & Nucl Med, Med Ctr, Amsterdam, Netherlands

 UCL Inst Neurol & Healthcare Engn, London, England

Zetterberg, H:
 Univ Gothenburg, Dept Psychiat & Neurochem, Molndal, Sweden

 Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden

 UCL, UK Dementia Res Inst, London, England

 UCL Inst Neurol, Dept Neurodegenerat Dis, London, England

Morgan, BP:
 Cardiff Univ, Dementia Res Inst Cardiff, Cardiff, Wales

Streffer, J:
 Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium

 UCB, Braine Lalleud, Belgium

 Janssen R&D LLC, Beerse, Belgium

Visser, PJ:
 Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Dept Psychiatty & Neuropsychol, Maastricht, Netherlands

 Vrije Univ Amsterdam Med Ctr, Alzheimer Ctr, Amsterdam, Netherlands

Lovestone, S:
 Univ Oxford, Dept Psychiat, Oxford, England

 Janssen R&D, Wycombe, England
ISSN: 13872877





JOURNAL OF ALZHEIMERS DISEASE
Editorial
IOS PRESS, NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS, Países Bajos
Tipo de documento: Article
Volumen: 74 Número: 1
Páginas: 213-225
WOS Id: 000519747800017
ID de PubMed: 31985466
imagen Green Published, Bronze, Green Accepted

MÉTRICAS